Zymtronix uses a cell-free platform to circumvent the limitations of cell production, resulting in less-expensive and faster molecule production. Their methods also reduce water, chemical, and energy usage, and waste production. Using synthetic biology Zymtronix can enhance enzyme expression and performance and make rare molecules more accessible globally. This technology simplifies downstream processing with their reusable enzyme carriers. Their cutting-edge approach holds promise for advancing enzymatic applications through scientific innovation and technological advancement. Their cell-free, biomanufacturing technology has applications across the food, nutrition, agriculture, cosmetics, and pharmaceutical industries. Zymtronix aims to improve the sustainability in manufacturing novel compounds.

Zymtronix

Founded: 2013
Location: Ithaca, NY
Employee range: 1-50
Funding: &lt;10M

Short description:

Drug notes:

Long description:

Jobs: